TY - JOUR AU - Neelam, K. AU - Cheung, C. M. AU - Ohno-Matsui, K. AU - Lai, T. Y. AU - Wong, T. Y. PY - 2012 DA - 2012// TI - Choroidal neovascularization in pathological myopia JO - Prog Retin Eye Res VL - 31 UR - https://doi.org/10.1016/j.preteyeres.2012.04.001 DO - 10.1016/j.preteyeres.2012.04.001 ID - Neelam2012 ER - TY - JOUR AU - Wong, T. Y. AU - Ferreira, A. AU - Hughes, R. AU - Carter, G. AU - Mitchell, P. PY - 2014 DA - 2014// TI - Epidemiology and disease burden of pathologic myopia and myopic choroidal neovascularization: an evidence-based systematic review JO - Am J Ophthalmol VL - 157 UR - https://doi.org/10.1016/j.ajo.2013.08.010 DO - 10.1016/j.ajo.2013.08.010 ID - Wong2014 ER - TY - JOUR AU - Ohno-Matsui, K. AU - Yoshida, T. AU - Futagami, S. AU - Yasuzumi, K. AU - Shimada, N. AU - Kojima, A. AU - Tokoro, T. AU - Mochizuki, M. PY - 2003 DA - 2003// TI - Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia JO - Br J Ophthalmol VL - 87 UR - https://doi.org/10.1136/bjo.87.5.570 DO - 10.1136/bjo.87.5.570 ID - Ohno-Matsui2003 ER - TY - STD TI - Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, et al: Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial–VIP report no. 3. Ophthalmology 2003, 110(4):667–673. ID - ref4 ER - TY - JOUR AU - Wolf, S. AU - Balciuniene, V. J. AU - Laganovska, G. AU - Menchini, U. AU - Ohno-Matsui, K. AU - Sharma, T. AU - Wong, T. Y. AU - Silva, R. AU - Pilz, S. AU - Gekkieva, M. PY - 2014 DA - 2014// TI - RADIANCE: a randomized controlled study of ranibizumab in patients with choroidal neovascularization secondary to pathologic myopia JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2013.10.023 DO - 10.1016/j.ophtha.2013.10.023 ID - Wolf2014 ER - TY - JOUR AU - Tufail, A. AU - Narendran, N. AU - Patel, P. J. AU - Sivaprasad, S. AU - Amoaku, W. AU - Browning, A. C. AU - Osoba, O. AU - Gale, R. AU - George, S. AU - Lotery, A. J. PY - 2013 DA - 2013// TI - Ranibizumab in myopic choroidal neovascularization: the 12-month results from the REPAIR study JO - Ophthalmology VL - 120 UR - https://doi.org/10.1016/j.ophtha.2013.06.010 DO - 10.1016/j.ophtha.2013.06.010 ID - Tufail2013 ER - TY - JOUR AU - Kasahara, K. AU - Moriyama, M. AU - Morohoshi, K. AU - Yoshida, T. AU - Simada, N. AU - Nagaoka, N. AU - Yokoi, T. AU - Shinohara, K. AU - Kaneko, Y. AU - Suga, M. PY - 2017 DA - 2017// TI - SIX-YEAR OUTCOMES OF INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION IN PATIENTS WITH PATHOLOGIC MYOPIA JO - Retina VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001313 DO - 10.1097/IAE.0000000000001313 ID - Kasahara2017 ER - TY - JOUR AU - Ikuno, Y. AU - Ohno-Matsui, K. AU - Wong, T. Y. AU - Korobelnik, J. F. AU - Vitti, R. AU - Li, T. AU - Stemper, B. AU - Asmus, F. AU - Zeitz, O. AU - Ishibashi, T. PY - 2015 DA - 2015// TI - Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization: The MYRROR Study JO - Ophthalmology VL - 122 UR - https://doi.org/10.1016/j.ophtha.2015.01.025 DO - 10.1016/j.ophtha.2015.01.025 ID - Ikuno2015 ER - TY - JOUR AU - Baba, T. AU - Kubota-Taniai, M. AU - Kitahashi, M. AU - Okada, K. AU - Mitamura, Y. AU - Yamamoto, S. PY - 2010 DA - 2010// TI - Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation JO - Br J Ophthalmol VL - 94 UR - https://doi.org/10.1136/bjo.2009.166025 DO - 10.1136/bjo.2009.166025 ID - Baba2010 ER - TY - STD TI - Cheung CMG, Arnold JJ, Holz FG, Park KH, Lai TYY, Larsen M, Mitchell P, Ohno-Matsui K, Chen SJ, Wolf S, et al: Myopic Choroidal Neovascularization: Review, Guidance, and Consensus Statement on Management. Ophthalmology 2017. ID - ref10 ER - TY - JOUR AU - Wang, E. AU - Chen, Y. PY - 2013 DA - 2013// TI - Intravitreal anti-vascular endothelial growth factor for choroidal neovascularization secondary to pathologic myopia: systematic review and meta-analysis JO - Retina VL - 33 UR - https://doi.org/10.1097/IAE.0b013e31827d260a DO - 10.1097/IAE.0b013e31827d260a ID - Wang2013 ER - TY - JOUR AU - Wang, Q. AU - Li, T. AU - Wu, Z. AU - Wu, Q. AU - Ke, X. AU - Luo, D. AU - Wang, H. PY - 2013 DA - 2013// TI - Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0070544 DO - 10.1371/journal.pone.0070544 ID - Wang2013 ER - TY - JOUR AU - Zhang, M. AU - Zhang, J. AU - Yan, M. AU - Luo, D. AU - Zhu, W. AU - Kaiser, P. K. AU - Yu, D. C. PY - 2011 DA - 2011// TI - A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration JO - Ophthalmology VL - 118 UR - https://doi.org/10.1016/j.ophtha.2010.08.008 DO - 10.1016/j.ophtha.2010.08.008 ID - Zhang2011 ER - TY - JOUR AU - Sun, Z. AU - Zhou, H. AU - Lin, B. AU - Jiao, X. AU - Luo, Y. AU - Zhang, F. AU - Tao, S. AU - Wu, Q. AU - Ke, Z. AU - Liu, X. PY - 2017 DA - 2017// TI - EFFICACY AND SAFETY OF INTRAVITREAL CONBERCEPT INJECTIONS IN MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION JO - Retina VL - 37 UR - https://doi.org/10.1097/IAE.0000000000001404 DO - 10.1097/IAE.0000000000001404 ID - Sun2017 ER - TY - JOUR AU - Qu, J. AU - Cheng, Y. AU - Li, X. AU - Yu, L. AU - Ke, X. PY - 2016 DA - 2016// TI - EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora Study JO - Retina VL - 36 UR - https://doi.org/10.1097/IAE.0000000000000875 DO - 10.1097/IAE.0000000000000875 ID - Qu2016 ER - TY - JOUR AU - Li, X. AU - Xu, G. AU - Wang, Y. AU - Xu, X. AU - Liu, X. AU - Tang, S. AU - Zhang, F. AU - Zhang, J. AU - Tang, L. AU - Wu, Q. PY - 2014 DA - 2014// TI - Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study JO - Ophthalmology VL - 121 UR - https://doi.org/10.1016/j.ophtha.2014.03.026 DO - 10.1016/j.ophtha.2014.03.026 ID - Li2014 ER - TY - JOUR AU - Xu, Y. AU - Rong, A. AU - Bi, Y. AU - Xu, W. PY - 2016 DA - 2016// TI - Intravitreal Conbercept Injection with and without Grid Laser Photocoagulation in the Treatment of Diffuse Diabetic Macular Edema in Real-Life Clinical Practice JO - J Ophthalmol VL - 2016 ID - Xu2016 ER - TY - JOUR AU - Kung, Y. H. AU - Wu, T. T. AU - Huang, Y. H. PY - 2014 DA - 2014// TI - One-year outcome of two different initial dosing regimens of intravitreal ranibizumab for myopic choroidal neovascularization JO - Acta Ophthalmol VL - 92 UR - https://doi.org/10.1111/aos.12457 DO - 10.1111/aos.12457 ID - Kung2014 ER - TY - JOUR AU - Yang, H. S. AU - Kim, J. G. AU - Kim, J. T. AU - Joe, S. G. PY - 2013 DA - 2013// TI - Prognostic factors of eyes with naive subfoveal myopic choroidal neovascularization after intravitreal bevacizumab JO - Am J Ophthalmol VL - 156 UR - https://doi.org/10.1016/j.ajo.2013.08.002 DO - 10.1016/j.ajo.2013.08.002 ID - Yang2013 ER - TY - JOUR AU - Brue, C. AU - Pazzaglia, A. AU - Mariotti, C. AU - Reibaldi, M. AU - Giovannini, A. PY - 2016 DA - 2016// TI - Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study JO - Eye (Lond) VL - 30 UR - https://doi.org/10.1038/eye.2015.199 DO - 10.1038/eye.2015.199 ID - Brue2016 ER -